期刊
NEUROLOGY
卷 101, 期 4, 页码 -出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0000000000207470
关键词
-
This article discusses the long-term neurologic safety in patients with B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy. It points out an error in the spelling of the second author's name, which has been corrected.
In the Disputes & Debates: Editors' Choice article Reader Response: Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy by Karschnia et al.,(1) the second author's name should be spelled Kai Rejeski. The article has been replaced by a corrected version. The editorial office regrets the error.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据